Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Galen Estrogen Ring Will Be Marketed By Warner Chilcott 260-Rep Force

Executive Summary

Galen's acquisition of Warner Chilcott will provide the Irish company with a 260-rep sales force for the U.S. launch of its intravaginal estrogen ring product expected in 2001.

You may also be interested in...



Galen HRT Ring Femring Will Be Approved By February Or March, CEO Predicts

Galen's estradiol ring product Femring will be approved by FDA in February or March, CEO Roger Boissonneault said in an earnings call Feb. 11

Galen HRT Ring Femring Will Be Approved By February Or March, CEO Predicts

Galen's estradiol ring product Femring will be approved by FDA in February or March, CEO Roger Boissonneault said in an earnings call Feb. 11

Lilly Sells Sarafem: Galen Adds Drug To Women’s Health Line For $295 Mil.

Galen is adding Sarafem to its line of women's health products through a $295 mil. deal with Lilly

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel